Clinical Trial

A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients

Study acronym: CanHep
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
to study the anti-tumor effect of cannabis oil (THC10% / CBD5%) in untreatable HCC patients based on mRECIST and RECIST criteria
Trial Details
NCT Number NCT06518434
Lead Sponsor University Medical Center Groningen
Conditions Hepatocellular Carcinoma, Cannabis
Enrollment 20 participants
Start Date 2021-04-15
Primary Completion 2027-04-15 (estimated)
Study Completion 2027-04-15 (estimated)
Updated on ClinicalTrials.gov 2024-07-24